Progestogen only contraception and endometrial break through bleeding

Angiogenesis

Volumn 8, Issue 2, 2005, Pages 117-126

  Smith, Oliver P Milling ^a   Critchley, Hilary O D ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Angiogenesis; Bleeding; Breakthrough; Contraception; Endometrium; Progestogens

Indexed keywords

CYPROTERONE ACETATE; DESOGESTREL; DROSPIRENONE; DYDROGESTERONE; ETONOGESTREL; ETYNODIOL DIACETATE; GESTAGEN; GESTODENE; LEVONORGESTREL; MATRIX METALLOPROTEINASE; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE; NORETHISTERONE ACETATE; NORGESTIMATE; NORGESTREL; PROGESTERONE; THROMBIN;

BREAKTHROUGH BLEEDING; CELL ACTIVATION; CONTRACEPTION; DRUG USE; ENDOMETRIUM; FERTILITY; HUMAN; MOLECULAR MECHANICS; MORPHOLOGY; PRIORITY JOURNAL; REVIEW; TREATMENT FAILURE; VASCULAR FRAGILITY; VASCULARIZATION;

ANGIOGENESIS INDUCING AGENTS; CONTRACEPTIVE AGENTS, FEMALE; ENDOMETRIUM; FEMALE; HUMANS; METRORRHAGIA; PROGESTERONE; RECEPTORS, STEROID;

EID: 28244474840     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10456-005-9003-z     Document Type: Review

References (74)

1. Nations U. World Population Prospects: The 2000 Revision. New York, 1999.
2. Findlay JK. Future directions for research on endometrial bleeding. Hum Reprod 1996; 11(Suppl 2): 179-83.
3. Odlind V, Fraser IS. Hormonal contraception and bleeding disturbances: A clinical overview. In D'Arcangues CF IS, Newton JR, Odlind V (eds): Contraception and Mechanisms of Endometrial Bleeding. Cambridge: Cambridge University Press 1990; 5-31.
4. Schnare SM. Progestin contraceptives. J Midwifery Womens Health 2002; 47(3): 157-66.
5. Collins J, Crosignani PG. Hormonal contraception without estrogens. Hum Reprod Update 2003; 9(4): 373-86.
6. Irvine GA, Campbell-Brown MB, Lumsden MA et al. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. Br J Obstet Gynaecol 1998; 105(6): 592-8.
7. Peers T, Stevens JE, Graham J, Davey A. Norplant implants in the UK: First year continuation and removals. Contraception 1996; 53(6): 345-51.
8. Noyes RWHA, Rock J. Dating the endometrial biopsy. Fertil Steril 1950; 1: 3-25.
9. Critchley HO, Brenner RM, Henderson TA et al. Estrogen receptor beta, but not estrogen receptor α, is present in the vascular endothelium of the human and nonhuman primate endometrium. J Clin Endocrinol Metab 2001; 86(3): 1370-8.
10. Critchley HOD. Endometrial effects of progestogens. Gynaecol Forum 2003; 8(3): 6-10.
11. Saunders PTK, Critchley HOD. Estrogen receptor subtypes in the female reproductive tract. Reprod Med Rev 2002; 10(3): 149-64.
12. Mulac-Jericevic B, Conneely OM. Reproductive tissue selective actions of progesterone receptors. Reproduction 2004; 128(2): 139-46.
13. Turgeon JL, McDonnell DP, Martin KA, Wise PM. Hormone therapy: Physiological complexity belies therapeutic simplicity. Science 2004; 304(5675): 1269-73.
14. Wang H, Critchley HO, Kelly RW et al. Progesterone receptor subtype B is differentially regulated in human endometrial stroma. Mol Hum Reprod 1998; 4(4): 407-12.
15. Lane GKR, Whitehead M. The effects of oestrogen and progestogens on endometrial biochemistry. In Studd JWM (ed): The Menopause. Oxford: Blackwell 1988; 213-26.
16. Hurskainen R, Salmi A, Paavonen J et al. Expression of sex steroid receptors and Ki-67 in the endometria of menorrhagic women: Effects of intrauterine levonorgestrel. Mol Hum Reprod 2000; 6(11): 1013-8.
17. Critchley HO, Wang H, Kelly RW et al. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system. Hum Reprod 1998; 13(5): 1210-7.
18. Critchley HO, Bailey DA, Au CL et al. Immunohistochemical sex steroid receptor distribution in endometrium from long-term subdermal levonorgestrel users and during the normal menstrual cycle. Hum Reprod 1993; 8(10): 1632-9.
19. Rodriguez-Manzaneque JC, Graubert M, Iruela-Arispe ML. Endothelial cell dysfunction following prolonged activation of progesterone receptor. Hum Reprod 2000; 15(Suppl 3): 39-47.
20. Lau TM, Witjaksono J, Affandi B, Rogers PA. Expression of progesterone receptor mRNA in the endometrium during the normal menstrual cycle and in Norplant users. Hum Reprod 1996; 11(12): 2629-34.
21. Pekonen F, Nyman T, Lahteenmaki P et al. Intrauterine progestin induces continuous insulin-like growth factor-binding protein-1 production in the human endometrium. J Clin Endocrinol Metab 1992; 75(2): 660-4.
22. Markee JE. Menstruation in intraocular endometrial transplants in the rhesus monkey. Contrib Embryol 1940; 28: 219-308.
23. Hickey M, Fraser I, Dwarte D, Graham S. Endometrial vasculature in Norplant users: Preliminary results from a hysteroscopic study. Hum Reprod 1996; 11(Suppl 2): 35-44.
24. Hickey M, Dwarte D, Fraser IS. Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding. Hum Reprod 2000; 15(7): 1509-14.
25. Song JY, Markham R, Russell P et al. The effect of high-dose medium- and long-term progestogen exposure on endometrial vessels. Hum Reprod 1995; 10(4): 797-800.
26. McGavigan CJ, Dockery P, Metaxa-Mariatou V et al. Hormonally mediated disturbance of angiogenesis in the human endometrium after exposure to intrauterine levonorgestrel. Hum Reprod 2003; 18(1): 77-84.
27. Hickey M, Fraser IS. The structure of endometrial microvessels. Hum Reprod 2000; 15(Suppl 3): 57-66.
28. Perrot-Applanat M, Ancelin M, Buteau-Lozano H et al. Ovarian steroids in endometrial angiogenesis. Steroids 2000; 65(10-11): 599-603.
29. Rogers PA, Au CL, Affandi B. Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel. Hum Reprod 1993; 8(9): 1396-404.
30. Hickey M, Simbar M, Young L et al. A longitudinal study of changes in endometrial microvascular density in Norplant implant users. Contraception 1999; 59(2): 123-9.
31. Simbar M, Manconi F, Markham R et al. A three-dimensional study of endometrial microvessels in women using the contraceptive subdermal levonorgestrel implant system, norplant(R). Micron 2004; 35(7): 589-95.
32. Charnock-Jones DS, Macpherson AM, Archer DF et al. The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium. Hum Reprod 2000; 15(Suppl 3): 85-95.
33. Hickey M, Simbar M, Markham R et al. Changes in vascular basement membrane in the endometrium of Norplant users. Hum Reprod 1999; 14(3): 716-21.
34. Rogers PA, Plunkett D, Affandi B. Perivascular smooth muscle α-actin is reduced in the endometrium of women with progestin-only contraceptive breakthrough bleeding. Hum Reprod 2000; 15(Suppl 3): 78-84.
35. Palmer JA, Lau TM, Hickey M et al. Immunohistochemical study of endometrial microvascular basement membrane components in women using Norplant. Hum Reprod 1996; 11(10): 2142-50.
36. Kelly FD, Tawia SA, Rogers PA. Immunohistochemical characterization of human endometrial microvascular basement membrane components during the normal menstrual cycle. Hum Reprod 1995; 10(2): 268-76.
37. Wonodirekso S, Hadisaputra W, Affandi B et al. Cytokeratin 8, 18 and 19 in endometrial epithelium of Norplant and norethisterone enanthate injectable progestogen contraceptive users. Hum Reprod 1996; 11(Suppl2): 144-9.
38. Smith SK. Regulation of angiogenesis in the endometrium. Trends Endocrinol Metab 2001; 12(4): 147-51.
39. Goodger AM, Rogers PA. Endometrial endothelial cell proliferation during the menstrual cycle. Hum Reprod 1994; 9(3): 399-405.
40. Rogers PA, Gargett CE. Endometrial angiogenesis. Angiogenesis 1998; 2(4): 287-94.
41. Gargett CE, Rogers PA. Human endometrial angiogenesis. Reproduction 2001; 121(2): 181-6.
42. Maisonpierre PC, Suri C, Jones PF et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277(5322): 55-60.
43. Albrecht ED, Aberdeen GW, Niklaus AL et al. Acute temporal regulation of vascular endothelial growth/permeability factor expression and endothelial morphology in the baboon endometrium by ovarian steroids. J Clin Endocrinol Metab 2003; 88(6): 2844-52.
44. Archer DF, Navarro FJ, Leslie S, Mirkin S. Effects of levonorgestrel, medroxyprogesterone acetate, norethindrone, and 17β-estradiol on vascular endothelial growth factor isomers 121 and 165 in Ishikawa cells. Fertil Steril 2004; 81(1): 165-70.
45. Sharkey AM, Day K, McPherson A et al. Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia. J Clin Endocrinol Metab 2000; 85(1): 402-9.
46. Lebovic DI, Shifren JL, Ryan IP et al. Ovarian steroid and cytokine modulation of human endometrial angiogenesis. Hum Reprod 2000; 15(Suppl 3): 67-77.
47. Sugino N, Kashida S, Karube-Harada A et al. Expression of vascular endothelial growth factor (VEGF) and its receptors in human endometrium throughout the menstrual cycle and in early pregnancy. Reproduction 2002; 123(3): 379-87.
48. Classen-Linke I, Alfer J, Krusche CA et al. Progestins, progesterone receptor modulators, and progesterone antagonists change VEGF release of endometrial cells in culture. Steroids 2000; 65(10-11): 763-71.
49. Hague S, MacKenzie IZ, Bicknell R, Rees MC. In-vivo angiogenesis and progestogens. Hum Reprod 2002; 17(3): 786-93.
50. Roopa BA, Loganath A, Singh K. The effect of a levonorgestrel-releasing intrauterine system on angiogenic growth factors in the endometrium. Hum Reprod 2003; 18(9): 1809-19.
51. Hyder SM, Murthy L, Stancel GM. Progestin regulation of vascular endothelial growth factor in human breast cancer cells. Cancer Res 1998; 58(3): 392-5.
52. Taylor RN, Lebovic DI, Hornung D, Mueller MD. Endocrine and paracrine regulation of endometrial angiogenesis. Ann N Y Acad Sci 2001; 943: 109-21.
53. Rees MC, Bicknell R. Angiogenesis in the endometrium. Angiogenesis 1998; 2(1): 29-35.
54. Zhang L, Mackenzie IZ, Rees MC, Bicknell R. Regulation of the expression of the angiogenic enzyme platelet-derived endothelial cell growth factor/thymidine phosphorylase in endometrial isolates by ovarian steroids and cytokines. Endocrinology 1997; 138(11): 4921-30.
55. Krikun G, Sakkas D, Schatz F et al. Endometrial angiopoietin expression and modulation by thrombin and steroid hormones: A mechanism for abnormal angiogenesis following long-term progestin-only contraception. Am J Pathol 2004; 164(6): 2101-7.
56. Lockwood CJ, Kumar P, Krikun G et al. Effects of thrombin, hypoxia, and steroids on interleukin-8 expression in decidualized human endometrial stromal cells: Implications for long-term progestin-only contraceptive-induced bleeding. J Clin Endocrinol Metab 2004; 89(3): 1467-75.
57. Runic R, Schatz F, Wan L et al. Effects of norplant on endometrial tissue factor expression and blood vessel structure. J Clin Endocrinol Metab 2000; 85(10): 3853-9.
58. Hickey M, Carati C, Manconi F et al. The measurement of endometrial perfusion in norplant users: A pilot study. Hum Reprod 2000; 15(5): 1086-91.
59. Krikun G, Critchley H, Schatz F et al. Abnormal uterine bleeding during progestin-only contraception may result from free radical-induced alterations in angiopoietin expression. Am J Pathol 2002; 161(3): 979-86.
60. Mirkin S, Navarro F, Archer DF. Hormone therapy and endometrial angiogenesis. Climacteric 2003; 6(4): 273-7.
61. Salamonsen LA, Zhang J, Hampton A, Lathbury L. Regulation of matrix metalloproteinases in human endometrium. Hum Reprod 2000; 15(Suppl 3): 112-9.
62. Critchley HO, Kelly RW, Brenner RM, Baird DT. The endocrinology of menstruation - a role for the immune system. Clin Endocrinol (Oxf) 2001; 55(6): 701-10.
63. Salamonsen LA, Butt AR, Hammond FR et al. Production of endometrial matrix metalloproteinases, but not their tissue inhibitors, is modulated by progesterone withdrawal in an in vitro model for menstruation. J Clin Endocrinol Metab 1997; 82(5): 1409-15.
64. Salamonsen LA, Lathbury LJ. Endometrial leukocytes and menstruation. Hum Reprod Update 2000; 6(1): 16-27.
65. Song JY, Russell P, Markham R et al. Effects of high dose progestogens on white cells and necrosis in human endometrium. Hum Reprod 1996; 11(8): 1713-8.
66. Lathbury LJ, Salamonsen LA. In-vitro studies of the potential role of neutrophils in the process of menstruation. Mol Hum Reprod 2000; 6(10): 899-906.
67. Zhang J, Nie G, Jian W et al. Mast cell regulation of human endometrial matrix metalloproteinases: A mechanism underlying menstruation. Biol Reprod 1998; 59(3): 693-703.
68. Vincent AJ, Zhang J, Ostor A et al. Matrix metalloproteinase-1 and -3 and mast cells are present in the endometrium of women using progestin-only contraceptives. Hum Reprod 2000; 15(1): 123-30.
69. Milne SA, Rakhyoot A, Drudy TA et al. Co-localization of matrix metalloproteinase-1 and mast cell tryptase in the human uterus. Mol Hum Reprod 2001; 7(6): 559-65.
70. Marbaix E, Vekemans M, Galant C et al. Circulating sex hormones and endometrial stromelysin-1 (matrix metalloproteinase-3) at the start of bleeding episodes in levonorgestrel-implant users. Hum Reprod 2000; 15(Suppl 3): 120-34.
71. Salamonsen LA, Woolley DE. Matrix metalloproteinases in normal menstruation. Hum Reprod 1996; 11(Suppl 2): 124-33.
72. Vincent AJ, Malakooti N, Zhang J et al. Endometrial breakdown in women using Norplant is associated with migratory cells expressing matrix metalloproteinase-9 (gelatinase B). Hum Reprod 1999; 14(3): 807-15.
73. Vincent AJ, Zhang J, Ostor A et al. Decreased tissue inhibitor of metalloproteinase in the endometrium of women using depot medroxyprogesterone acetate: A role for altered endometrial matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in the pathogenesis of abnormal uterine bleeding? Hum Reprod 2002; 17(5): 1189-98.
74. Galant C, Berliere M, Dubois D et al. Focal expression and final activity of matrix metalloproteinases may explain irregular dysfunctional endometrial bleeding. Am J Pathol 2004; 165(1): 83-94.